EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metformin Inhibits Trophoblast Ferroptosis by Suppressing ATF2 and Activating the PI3K /Akt/Nrf2 Pathway to Improve Gestational Diabetes Mellitus

Dandan Xia iD, Yuhui Zhang iD, Wenjie Liu iD, Siyu Li iD, Chenying Zhang iD, Guangtong She iD, Huiyan Wang iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202602249rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Dandan Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Cha…. Hauptthemen laut MEDLINE: Ferroptosis, Metformin, NF-E2-Related Factor 2, Diabetes, Gestational. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: High-Level Leading Talents Project of Changzhou Health Commission, Changzhou Sci&Tech Program, Changzhou Municipal Health Commission Youth Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gestational diabetes mellitus (GDM) is a common metabolic disorder during pregnancy. Metformin (MET) has emerged as a promising alternative to insulin, but its mechanism of action in the placenta remains incompletely understood. In this study, we aimed to examine whether MET counteracts high‐glucose‐induced ferroptosis by regulating activating transcription factor 2 (ATF2) and to delineate the underlying molecular mechanism in GDM. We established in vitro GDM cell models using HTR‐8/SVneo trophoblast cells and an in vivo STZ‐induced hyperglycemic rat model, followed by treatments including ATF2 lentiviral manipulation and MET administration. We evaluated cell viability, ferroptosis markers (ROS, MDA, GSH, iron deposition), and PI3K/Akt signaling pathway activity. Our results demonstrated that in GDM patients and high‐glucose‐challenged HTR‐8/SVneo cells, MET promoted cell viability by suppressing ATF2, reactivating PI3K/Akt signaling, enhancing nuclear Nrf2 translocation, and upregulating GPX4, while concurrently lowering ROS and MDA levels, elevating GSH, and reducing iron deposition. These protective effects were reversed by ATF2 overexpression or pathway inhibitors. In STZ‐induced hyperglycemic rats, MET decreased placental ATF2 expression, restored the PI3K/Akt‐Nrf2‐GPX4 axis, alleviated ferroptosis, and reduced fetal weight. Collectively, our findings indicate that MET suppresses ATF2, activates PI3K/Akt, drives Nrf2 nuclear import, upregulates GPX4, and curbs high‐glucose‐induced trophoblast ferroptosis, offering new mechanistic insight and therapeutic avenues for GDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMetforminNF-E2-Related Factor 2Diabetes, GestationalTrophoblastsActivating Transcription Factor 2FemalePregnancyAnimalsRatsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesHumansSignal TransductionRats, Sprague-DawleyHypoglycemic AgentsCell LineDiabetes Mellitus, ExperimentalCell Survival

Stichwörter der Autor:innen

ATF2PI3K/Akt/Nrf2 signaling pathwayferroptosisgestational diabetes mellitusmetformin

Substanzen

MetforminNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktActivating Transcription Factor 2Phosphatidylinositol 3-KinasesHypoglycemic AgentsNfe2l2 protein, ratATF2 protein, humanAtf2 protein, rat

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, China.
  • Changzhou Key Laboratory of Maternal and Child Health Medicine, Changzhou, Jiangsu, China.

ORCID-Profile: Dandan Xia, Yuhui Zhang, Wenjie Liu, Siyu Li, Chenying Zhang, Guangtong She, Huiyan Wang

Förderung

  • High-Level Leading Talents Project of Changzhou Health Commission
  • Changzhou Sci&Tech Program
  • Changzhou Municipal Health Commission Youth Project

Zitieren

APA

Xia, D., Zhang, Y., Liu, W., Li, S., Zhang, C., She, G., & Wang, H. (2026). Metformin Inhibits Trophoblast Ferroptosis by Suppressing ATF2 and Activating the PI3K /Akt/Nrf2 Pathway to Improve Gestational Diabetes Mellitus. The FASEB Journal. https://doi.org/10.1096/fj.202602249rr

Vancouver

Xia D, Zhang Y, Liu W, Li S, Zhang C, She G, et al. Metformin Inhibits Trophoblast Ferroptosis by Suppressing ATF2 and Activating the PI3K /Akt/Nrf2 Pathway to Improve Gestational Diabetes Mellitus. The FASEB Journal. 2026. doi:10.1096/fj.202602249rr

BibTeX
@article{Xia2026,
  author = {Xia, Dandan and Zhang, Yuhui and Liu, Wenjie and Li, Siyu and Zhang, Chenying and She, Guangtong and Wang, Huiyan},
  title = {Metformin Inhibits Trophoblast Ferroptosis by Suppressing ATF2 and Activating the PI3K /Akt/Nrf2 Pathway to Improve Gestational Diabetes Mellitus},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202602249rr}
}
Kostenlos starten →